摘要
早在2010年11月9日，卫生部就“肖氏反射弧”进行了首次回应，卫生部新闻发言人邓海华在例行新闻发布会上表示，经卫生部组织专家进行多次研究，“肖氏反射弧”技术的安全性、有效性的循证医学证据不足，该技术是否适用于临床应用，还要进行充分论证。
November 9th, 2010, Ministry of Health concluded that 'Xiao Procedure' lacked clinical evidence on its safety and effectiveness, and needed further proof whether it could be put into clinical use. This incident highlights the broken chain of regulation for new healthcare technology. The grey area exists in the clinical test and approval of innovative healthcare technology.
出处
《中国医院院长》
2011年第2期28-31,6,共4页
China Hospital CEO
